Chao Lin
Research Subjects
Chao Lin has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Le Xu
School of Physics and Information Engineering, Jiangsu Province Engineering Research Center of Basic Education Big Data Application, Jiangsu Second Normal University, Nanjing, 210013, China
2 shared publications - Ligang Ma
School of Electronic Engineering, Nanjing Xiaozhuang University, Nanjing 211171, China
2 shared publications Peiwu Li
Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Shandong, P. R. of China
2 shared publicationsQi Xing
Yantai Key Laboratory of Nanomedicine & Advanced Preparations Yantai Institute of Materia Medica Shandong 264000 P.R. China
2 shared publications- Xiaoqian Ai
School of Physics and Information Engineering, Jiangsu Province Engineering Research Center of Basic Education Big Data Application, Jiangsu Second Normal University, Nanjing, 210013, China
2 shared publications Bo Li
1 shared publication
Latest Publications
- 13 August 2024
- Published by Elsevier in International Journal of Hydrogen Energy
- Vol. 83, 553-562
ZnIn2S4 nanostructure grown on electronegative h-BN for highly efficient photocatalytic hydrogen evolution
- 13 August 2024
- Published by Elsevier in International Journal of Hydrogen Energy
- Vol. 83, 553-562
ZnIn2S4 nanostructure grown on electronegative h-BN for highly efficient photocatalytic hydrogen evolution
- 21 June 2024
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 15 (7) , 2413-2421
Identification of AdipoRon analogues as novel activators of AMPK for the treatment of type 2 diabetes
The activation of AMPK has emerged as a promising therapeutic approach for the treatment of metabolic diseases. AdipoRon, an agonist of the adiponectin receptor, has been identified as a compound capable of activating AMPK via the adiponectin receptor. To identify novel AdipoRon analogues with AMPK activation potential, a total of 17 analogues were designed, synthesized, and subjected to biological evaluation. Among these analogues, X-12 was discovered to exhibit potent activation of AMPK. In experimental studies, X-12 demonstrated dose-dependent improvements in glucose tolerance in normal mice. Furthermore, it significantly reduced fasting blood glucose levels and ameliorated insulin resistance in db/db diabetic mice. These findings highlight the therapeutic potential of X-12 as a novel class of AMPK activators for the treatment of metabolic diseases.
- 21 June 2024
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 15 (7) , 2413-2421
Identification of AdipoRon analogues as novel activators of AMPK for the treatment of type 2 diabetes
The activation of AMPK has emerged as a promising therapeutic approach for the treatment of metabolic diseases. AdipoRon, an agonist of the adiponectin receptor, has been identified as a compound capable of activating AMPK via the adiponectin receptor. To identify novel AdipoRon analogues with AMPK activation potential, a total of 17 analogues were designed, synthesized, and subjected to biological evaluation. Among these analogues, X-12 was discovered to exhibit potent activation of AMPK. In experimental studies, X-12 demonstrated dose-dependent improvements in glucose tolerance in normal mice. Furthermore, it significantly reduced fasting blood glucose levels and ameliorated insulin resistance in db/db diabetic mice. These findings highlight the therapeutic potential of X-12 as a novel class of AMPK activators for the treatment of metabolic diseases.
- 9 January 2024
- Published by Elsevier in International Journal of Hydrogen Energy
- Vol. 57, 290-300
In-situ constructing ZnIn2S4@In(OH)3@CdS heterostructure for efficient photocatalytic H2 generation under visible light irradiation
- 9 January 2024
- Published by Elsevier in International Journal of Hydrogen Energy
- Vol. 57, 290-300
In-situ constructing ZnIn2S4@In(OH)3@CdS heterostructure for efficient photocatalytic H2 generation under visible light irradiation
- 5 June 2023
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 26 (25)
A One‐Pot Approach to Multi‐Substituted Fused Aziridines: Formal Intermolecular [2+1] Cycloaddition Reaction between Saccharin‐Derived Cyclic Ketimines and Sulfur Ylides
Herein a concise and efficient method for the synthesis of aziridines has been developed. The reaction proceeds through a formal intermolecular [2+1] cycloaddition reaction of saccharin‐derived cyclic ketimines with sulfur ylides. This methodology features high atom‐economy, broad substrate scope and an operationally simple procedure, affording the aziridines with excellent yields and diastereoselectivity (>20 : 1 dr). In the presence of base, the aziridine products could be readily converted to benzothiazines by an unusual rearrangement reaction.
- 5 June 2023
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 26 (25)
A One‐Pot Approach to Multi‐Substituted Fused Aziridines: Formal Intermolecular [2+1] Cycloaddition Reaction between Saccharin‐Derived Cyclic Ketimines and Sulfur Ylides
Herein a concise and efficient method for the synthesis of aziridines has been developed. The reaction proceeds through a formal intermolecular [2+1] cycloaddition reaction of saccharin‐derived cyclic ketimines with sulfur ylides. This methodology features high atom‐economy, broad substrate scope and an operationally simple procedure, affording the aziridines with excellent yields and diastereoselectivity (>20 : 1 dr). In the presence of base, the aziridine products could be readily converted to benzothiazines by an unusual rearrangement reaction.
- Open Access
- 4 March 2022
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 173, 106162
Pharmacokinetics, tissue distribution and excretion of compound 6c, a novel DPP-4 inhibitor, following intragastric administration in rats by ultra-performance liquid chromatography-tandem mass spectrometry
- 4 March 2022
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 173, 106162
Open AccessPharmacokinetics, tissue distribution and excretion of compound 6c, a novel DPP-4 inhibitor, following intragastric administration in rats by ultra-performance liquid chromatography-tandem mass spectrometry
- Open Access
- 24 May 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (30) , 18576-18579
A formal intermolecular [4 + 1] cycloaddition reaction of 3-chlorooxindole and o -quinone methides: a facile synthesis of spirocyclic oxindole scaffolds
Herein, we developed an efficient and straightforward method for the rapid synthesis of spirocyclic oxindole scaffolds via the [4 + 1] cyclization reaction of 3-chlorooxindole with o-quinone methides (o-QMs), which were generated under mild conditions. The products could be obtained in excellent yields with numerous types of 3-chlorooxindole. This methodology features mild reaction conditions, high atom-economy and broad substrate scope.
- 24 May 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (30) , 18576-18579
Open AccessA formal intermolecular [4 + 1] cycloaddition reaction of 3-chlorooxindole and o -quinone methides: a facile synthesis of spirocyclic oxindole scaffolds
Herein, we developed an efficient and straightforward method for the rapid synthesis of spirocyclic oxindole scaffolds via the [4 + 1] cyclization reaction of 3-chlorooxindole with o-quinone methides (o-QMs), which were generated under mild conditions. The products could be obtained in excellent yields with numerous types of 3-chlorooxindole. This methodology features mild reaction conditions, high atom-economy and broad substrate scope.